Natera, Inc.
Market Cap
$28.12B
P/E Ratio
-130.51
EPS
$-1.52
Dividend Yield
0.00%
52-Week Range
$125.38 — $256.36
Volume
1.12M
Avg Volume
1.17M
Beta
1.70
P/E (TTM)
-130.51
Forward P/E
—
PEG Ratio
-4.02
P/S (TTM)
12.28
P/B (TTM)
16.21
P/FCF
902.01
EV/EBITDA
-277.71x
EV/Sales
—
ROE (TTM)
-0.15%
ROA (TTM)
-0.08%
ROIC
-0.07%
Gross Margin
0.65%
Operating Margin
-0.13%
Net Margin
-0.15%
Debt/Equity
0.13
Current Ratio
3.39
EPS Growth (YoY)
-1.50%
Revenue Growth (YoY)
+0.21%
EPS Growth (3Y)
+0.28%
EPS Growth (5Y)
-0.11%
Sales Growth (3Y)
+0.40%
Sales Growth (5Y)
+0.42%
EPS Est (This Year)
$-1.91
EPS Est (Next Year)
$-0.24
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$7.87
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $251.88(27.0% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-336195
Outstanding Shares
138.32M
Float
133.76M
Free Float %
96.70%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
NASDAQ
IPO Date
2015-07-01
Employees
4424
CEO
Steven Leonard Chapman
Index Membership
—
Website
https://www.natera.com
Natera, Inc. (NTRA) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $28.12B, a P/E ratio of -130.51, NTRA is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NTRA against other stocks using dozens of fundamental and technical filters.
Natera, Inc. (NTRA) has a trailing twelve-month (TTM) P/E ratio of -130.51. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Natera, Inc. (NTRA) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Natera, Inc. (NTRA) has a market capitalization of $28.12 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Natera, Inc. (NTRA) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $251.88 implies 27.0% upside from the current price.